I've had a question buried in my brain for a while and wondered if gfp and Neuro might have an answer, her she is: We own the MOU patents on AMPA upmodulation worldwide. Whatever or how did the SSRI patents develop and how did they become so non - compartmentalised so to speak, not under one small roof -? I guess nonone was allowed such a deep IP and therefore patents became molecular and with some MOU or nerotransmitter or another. On another subject- I am thinking from a technical front( chartist) we could be forming a reverse head and shoulders bottom, the left shoulder being the small base @$1.65-1.70 the head right here @ 1.45 and we need another shoulder up around $1.65 or higher. this is a powerfull bottoming formation. The bull move would occur when you break the neckline above 1.70 This will need time to form- BUT it is often THE most conclusive bottom formation in stock charting. It would also coincide with the better news that would- will, could( hopefully) come in 1st quarter, where the higher priced stock from the rally this year would well likely have been sold( BARFED) to strong hands. My experience in big moves in stocks is there is often an event which delivers the upmove when the shareholder base has been delivered a disconnect previously -- this is happened in the upmove in commodity related stocks starting in 2002- Oils ect...Real estate reits ect...in 2000...GOLD same time...But also broadly technology in the late 80's- Biotech and pharma right after the Hillary scare in 1993-94.In other words, the time to be in is when the masses are selling out, and risk is low. There is no way to relate this to Cortex, it is not that simple to correlate now other than the huge collapse will result in a lot of stock being distributed, accumulated as well right before we get to the meat of Cortex's possibility.Thanks again to all the posters for the great insight and I hope that you all had a nice respite this long Thanksgiving weekend.
News 
Market Data 
Discover 
AI
